PTC Therapeutics, Huntington's
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
PTC Therapeutics (NASDAQ: PTCT) announced today that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's disease. Fast Track designation is awarded to promising therapies for diseases of high unmet need.
PTC Therapeutics' Huntington's Treatment Gets FDA Fast Track Designation
PTC Therapeutics' treatment for Huntington's disease has received a fast track designation from U.S. health regulators. The biopharmaceutical company said Thursday that the Food and Drug Administration granted the designation to the PTC518 program which aims to reduce the production of mutated Huntington protein.
A Hurricane Watch is in place for most of the Big Bend. Because of the quick speed of this system, we should see the ...
Potential Tropical Cyclone 9 could become a landfalling major hurricane for the Florida Gulf Coast on Thursday.
The National Hurricane Center designated Potential Tropical Cyclone Nine on Monday allowing forecasters to begin putting out a track for the tropical threat. PTC Nine is expected to become Hurricane ...
We have no weather worries in the short term, but the forecast is looking more active for the middle and end of the week as ...
Helene is expected to intensify into an unusually large major hurricane that will bring a historic storm surge to a large ...
Sens. Jacky Rosen (D-Nevada) and Tammy Baldwin (D-Wisc.) will introduce a bill Wednesday that would allow a tax write off of ...
Purchasing an iPhone has never been easier, thanks to Blinkit, a quick commerce platform that has launched its lightning-fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback